Literature DB >> 14984496

Biological diagnosis of primary intraocular lymphoma.

Hélène Merle-Béral1, Frédéric Davi, Nathalie Cassoux, Sylvie Baudet, Chantal Colin, Thomas Gourdet, Bahram Bodaghi, Phuc LeHoang.   

Abstract

Primary intraocular lymphoma (PIOL) is a rare presentation of lymphoma that is particularly difficult to recognize. In our institution, 36 cases of PIOL were diagnosed between March 1997 and July 2002. The recognition of lymphoma cells by cytology with or without immunophenotyping on slides generated a strong suspicion of the diagnosis in 34 of 36 cases. The diagnosis was confirmed by measurement of interleukin-10 (IL-10) in the vitreous humour or aqueous humour; high levels were observed in 35 of 36 cases, all were of B-cell origin. As expected, the only case with T-cell lymphoma had a very low level of IL-10. Furthermore, IL-10 levels excluded this diagnosis in two cases that were incorrectly suspected of PIOL after cytological examination. Finally, detection of clonality by polymerase chain reaction techniques, performed in 29 cases, represented a helpful tool in diagnosing PIOL as this approach definitively confirmed the diagnosis of B- or T-cell lymphoma in 17 cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984496     DOI: 10.1046/j.1365-2141.2003.04800.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  29 in total

1.  Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma.

Authors:  Keisuke Kimura; Yoshihiko Usui; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2012-06-05       Impact factor: 2.447

2.  Primary testicular and intraocular lymphomas: two case reports and a review of the literature.

Authors:  Dana J Wallace; Chandra R Altemare; De Fen Shen; Marc D deSmet; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 6.048

Review 3.  Pathophysiology of retinal lymphoma.

Authors:  Sarah E Coupland; Chi Chao Chan; Justine Smith
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

4.  Diagnosis of systemic metastatic retinal lymphoma.

Authors:  Xiaoguang Cao; Defen Shen; David G Callanan; Manabu Mochizuki; Chi-Chao Chan
Journal:  Acta Ophthalmol       Date:  2011-03       Impact factor: 3.761

5.  [Primary vitreoretinal lymphoma].

Authors:  D Jaehne; S E Coupland
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

Review 6.  Primary intraocular lymphoma of T-cell type: report of a case and review of the literature.

Authors:  Sarah E Coupland; Gerasimos Anastassiou; Norbert Bornfeld; Michael Hummel; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

7.  Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome).

Authors:  Sarah E Coupland; Alexandra Perez-Canto; Michael Hummel; Harald Stein; Heinrich Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-21       Impact factor: 3.117

8.  Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.

Authors:  Laura S Hiemcke-Jiwa; Ninette H Ten Dam-van Loon; Roos J Leguit; Stefan Nierkens; Jeannette Ossewaarde-van Norel; Joke H de Boer; Floor F Roholl; Roel A de Weger; Manon M H Huibers; Jolanda D F de Groot-Mijnes; Jonas J W Kuiper
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

9.  The future of primary intraocular lymphoma (retinal lymphoma).

Authors:  Chi-Chao Chan; Sylvain Fisson; Bahram Bodaghi
Journal:  Ocul Immunol Inflamm       Date:  2009 Nov-Dec       Impact factor: 3.070

10.  IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.

Authors:  Nathalie Cassoux; Alain Giron; Bahram Bodaghi; Thi H C Tran; Sylvie Baudet; Fréderic Davy; Chi C Chan; Phuc Lehoang; Hélène Merle-Béral
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.